Helix BioMedix, Inc.

HXBMOTCHealthcare● Active

$1.79

+$0.00(+0.00%)

Market Cap$402227

P/E Ratio—

52W High$6.45

52W Low$1

Avg Volume39

Open$1.70

Beta1.34

Overview

Helix BioMedix, Inc. (HXBM) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HXBM · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2012Report Date: Nov 9, 2012

EPS Actual

-$6.06

Revenue

—

Fiscal Period

Q4 FY2012

FY ends December

Report Date

Nov 9, 2012

After Market Close

HXBM reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q4 FY2012	Nov 9, 2012	—	-$6.06	—	—	—	—

Q4 FY2012

Nov 9, 2012

EPS Actual

-$6.06

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for HXBM.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2012	Nov 9, 2012	—	$54.00	$54.00	+0.00%

Q4 FY2012+0.00%

Report Date

Nov 9, 2012

EPS Beat/Miss

—

Price Before

$54.00

Price After

$54.00

Beat Rate0 / 1 quarters

Largest Move+0.00% (Q4 FY2012)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Helix BioMedix, Inc. (HXBM) most recently reported earnings on November 9, 2012 for Q4 FY2012, posting EPS of $-6.06 (in line with the analyst consensus of —). The next HXBM earnings date is expected around September 1, 2026.

Each quarter, investors track HXBM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HXBM revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

HXBM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

HXBM earnings · 4 questions

Helix BioMedix, Inc.'s next earnings report is expected around September 1, 2026. HXBM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HXBM historically reports after market close (AMC).

HXBM earnings datewhen is HXBM earningsHXBM next earnings datewhen does HXBM report earningsHXBM earnings calendar

▸ Source: FMP · Helix BioMedix, Inc. SEC filings · US GAAP · Helix BioMedix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026